C R Bard Company Profile (NYSE:BCR)

About C R Bard (NYSE:BCR)

C R Bard logoC. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs.

Industry, Sector and Symbol:
  • Sector:
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:BCR
  • CUSIP: 06738310
  • Web: www.crbard.com
Capitalization:
  • Market Cap: $22.36 billion
  • Outstanding Shares: 72,417,000
Average Prices:
  • 50 Day Moving Avg: $289.55
  • 200 Day Moving Avg: $247.02
  • 52 Week Range: $203.63 - $309.16
P/E:
  • Trailing P/E Ratio: 39.29
  • Foreward P/E Ratio: 23.91
  • P/E Growth: 2.29
Sales & Book Value:
  • Annual Revenue: $3.78 billion
  • Price / Sales: 5.91
  • Book Value: $23.09 per share
  • Price / Book: 13.37
Dividend:
  • Annual Dividend: $1.04
  • Dividend Yield: 0.3%
Profitability:
  • EBIDTA: $1.16 billion
  • Net Margins: 14.31%
  • Return on Equity: 48.48%
  • Return on Assets: 14.81%
Debt:
  • Debt-to-Equity Ratio: 0.95%
  • Current Ratio: 2.63%
  • Quick Ratio: 2.07%
Misc:
  • Average Volume: 935,502 shs.
  • Beta: 0.63
  • Short Ratio: 3.21
 

Frequently Asked Questions for C R Bard (NYSE:BCR)

What is C R Bard's stock symbol?

C R Bard trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCR."

How often does C R Bard pay dividends? What is the dividend yield for C R Bard?

C R Bard declared a quarterly dividend on Wednesday, April 19th. Shareholders of record on Monday, May 1st will be paid a dividend of $0.26 per share on Friday, May 12th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date is Thursday, April 27th. View C R Bard's Dividend History.

How were C R Bard's earnings last quarter?

C R Bard Inc (NYSE:BCR) released its quarterly earnings data on Sunday, April, 23rd. The company reported $2.87 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $2.65 by $0.22. The firm had revenue of $938.80 million for the quarter, compared to analysts' expectations of $916.15 million. C R Bard had a net margin of 14.31% and a return on equity of 48.48%. The firm's quarterly revenue was up 7.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.34 earnings per share. View C R Bard's Earnings History.

When will C R Bard make its next earnings announcement?

C R Bard is scheduled to release their next quarterly earnings announcement on Monday, July, 24th 2017. View Earnings Estimates for C R Bard.

What guidance has C R Bard issued on next quarter's earnings?

C R Bard updated its FY17 earnings guidance on Monday, April, 24th. The company provided earnings per share guidance of $11.65-11.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $11.65. The company issued revenue guidance of +6-7% YoY to $3.95-3.99 billion, compared to the consensus revenue estimate of $3.89 billion.

Where is C R Bard's stock going? Where will C R Bard's stock price be in 2017?

13 brokers have issued 12 month target prices for C R Bard's stock. Their forecasts range from $225.00 to $317.00. On average, they anticipate C R Bard's stock price to reach $258.50 in the next twelve months. View Analyst Ratings for C R Bard.

What are analysts saying about C R Bard stock?

Here are some recent quotes from research analysts about C R Bard stock:

  • 1. According to Zacks Investment Research, "C. R. Bard reported stellar first-quarter 2017 results, crushing the Zacks Consensus Estimate on both counts, courtesy of growth from each of its four businesses both domestically and internationally. The company has gained prominence in the market with an expanding product portfolio and continuing regulatory approvals. The growing adoption of Lutonix DCB is expected to drive top-line growth in the coming quarters. Over the past one year, C. R. Bard has outperformed the broader industry trends with respect to price performances. The company is slated to be acquired by Becton, Dickinson and Company for $24 billion. The acquisition is expected to close by fall 2017. We believe the latest development will provide benefits to the combined entity and bolster its foothold in the global medical devices market, which is expected to reach a worth of $543.9 billion by 2020." (5/12/2017)
  • 2. Needham & Company LLC analysts commented, "BCR’s 4Q16 revenue and EPS beat consensus and management provided initial 2017 revenue guidance that was in line with consensus and EPS guidance that was above consensus. Organic revenue growth improved to 6.9% in 4Q16 from 6.4% in 3Q16. Although BCR’s gross margin declined slightly, its operating margin improved by 150 bps Y/Y due to significant SG&A leverage." (1/27/2017)

Are investors shorting C R Bard?

C R Bard saw a decrease in short interest in April. As of April 28th, there was short interest totalling 579,444 shares, a decrease of 50.2% from the April 13th total of 1,163,215 shares. Based on an average daily trading volume, of 2,488,702 shares, the short-interest ratio is presently 0.2 days. Currently, 0.8% of the company's shares are sold short.

Who are some of C R Bard's key competitors?

Who are C R Bard's key executives?

C R Bard's management team includes the folowing people:

  • Timothy M. Ring, Chairman of the Board, Chief Executive Officer
  • John H. Weiland, President, Vice Chairman of the Board, Chief Operating Officer
  • James C. Beasley, Group President
  • Timothy P. Collins, Group President
  • John P. Groetelaars, Group President
  • Christopher S. Holland, Chief Financial Officer, Senior Vice President
  • Samrat S. Khichi, Senior Vice President, General Counsel, Secretary
  • John A. DeFord Ph.D., Senior Vice President - Science, Technology and Clinical Affairs
  • Frank Lupisella Jr., Vice President, Controller
  • Betty D. Larson, Vice President - Human Resources

Who owns C R Bard stock?

C R Bard's stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.88%), BlackRock Inc. (10.22%), State Street Corp (5.29%), Bank of New York Mellon Corp (4.10%), Fundsmith LLP (3.54%) and Principal Financial Group Inc. (1.62%). Company insiders that own C R Bard stock include Anthony Welters, Betty D Larson, Christopher S Holland, Frank Lupisella Jr, Frank Lupisella, Jr, Gail K Naughton, Jim C Beasley, John A Deford, John H Weiland, John P Groetelaars, Patricia G Christian, Sharon M Luboff, Timothy M Ring, Timothy P Collins, Tommy G Thompson and Tony L White. View Institutional Ownership Trends for C R Bard.

Who sold C R Bard stock? Who is selling C R Bard stock?

C R Bard's stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Findlay Park Partners LLP, Yacktman Asset Management LP, Victory Capital Management Inc., Bank of Montreal Can, AQR Capital Management LLC, Prudential Financial Inc. and Acadian Asset Management LLC. Company insiders that have sold C R Bard stock in the last year include Betty D Larson, Christopher S Holland, Frank Lupisella Jr, Frank Lupisella, Jr, Gail K Naughton, Jim C Beasley, John A Deford, John H Weiland, John P Groetelaars, Sharon M Luboff, Timothy M Ring and Timothy P Collins. View Insider Buying and Selling for C R Bard.

Who bought C R Bard stock? Who is buying C R Bard stock?

C R Bard's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P., Renaissance Technologies LLC, Alliancebernstein L.P., Old Mutual Global Investors UK Ltd., Mackenzie Financial Corp and Vanguard Group Inc.. View Insider Buying and Selling for C R Bard.

How do I buy C R Bard stock?

Shares of C R Bard can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is C R Bard's stock price today?

One share of C R Bard stock can currently be purchased for approximately $308.70.


MarketBeat Community Rating for C R Bard (NYSE BCR)
Community Ranking:  1.7 out of 5 ()
Outperform Votes:  204 (Vote Outperform)
Underperform Votes:  408 (Vote Underperform)
Total Votes:  612
MarketBeat's community ratings are surveys of what our community members think about C R Bard and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for C R Bard (NYSE:BCR) (?)
Ratings Breakdown: 11 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.15)
Consensus Price Target: $258.50 (16.26% downside)

Analysts' Ratings History for C R Bard (NYSE:BCR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/26/2017Raymond James Financial, Inc.DowngradeStrong-Buy -> Mkt PerformLowView Rating Details
4/25/2017Wells Fargo & CoDowngradeOutperform -> Market PerformLowView Rating Details
4/25/2017BMO Capital MarketsDowngradeOutperform -> Market Perform$245.00LowView Rating Details
4/24/2017Morgan StanleyDowngradeOverweight -> Equal WeightLowView Rating Details
4/24/2017Cowen and CompanyBoost Price TargetMarket Perform$240.00 -> $317.00HighView Rating Details
4/24/2017Jefferies Group LLCBoost Price TargetHold$237.00 -> $317.00HighView Rating Details
1/29/2017Barclays PLCReiterated RatingHold$245.00N/AView Rating Details
1/27/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
1/27/2017JMP SecuritiesBoost Price Target$240.00 -> $255.00N/AView Rating Details
9/15/2016Evercore ISIInitiated CoverageBuy$235.00N/AView Rating Details
7/28/2016Leerink SwannReiterated RatingMarket Perform$240.00 -> $233.00N/AView Rating Details
7/27/2016JPMorgan Chase & Co.Boost Price TargetNeutral$214.00 -> $225.00N/AView Rating Details
7/27/2016Citigroup IncBoost Price TargetBuy$241.00 -> $265.00N/AView Rating Details
7/27/2016Deutsche Bank AGBoost Price TargetHold$234.00 -> $240.00N/AView Rating Details
7/8/2016Bank of America CorpDowngradeBuy -> NeutralN/AView Rating Details
5/24/2016Piper Jaffray CompaniesReiterated RatingBuy$241.00N/AView Rating Details
3/17/2016NomuraInitiated CoverageNeutral$205.00N/AView Rating Details
1/29/2016Goldman Sachs Group IncLower Price TargetBuy$214.00 -> $211.00N/AView Rating Details
10/23/2015Brean CapitalReiterated RatingHoldN/AView Rating Details
10/23/2015William BlairReiterated RatingHoldN/AView Rating Details
8/27/2015KeyCorpInitiated CoverageSector WeightN/AView Rating Details
(Data available from 5/30/2015 forward)

Earnings

Earnings History for C R Bard (NYSE:BCR)
Earnings by Quarter for C R Bard (NYSE:BCR)
Earnings History by Quarter for C R Bard (NYSE BCR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2017        
4/23/2017Q1 2017$2.65$2.87$916.15 million$938.80 millionViewN/AView Earnings Details
1/26/2017Q416$2.74$2.77$956.12 million$967.10 millionViewListenView Earnings Details
10/25/2016Q3$2.55$2.64$931.66 million$941.90 millionViewListenView Earnings Details
7/26/2016Q2$2.47$2.54$915.22 million$931.50 millionViewListenView Earnings Details
4/27/2016Q116$2.17$2.34$845.77 million$873.50 millionViewListenView Earnings Details
1/28/2016Q415$2.41$2.43$867.22 million$870.80 millionViewListenView Earnings Details
10/22/2015Q3$2.24$2.28$852.93 million$865.70 millionViewListenView Earnings Details
7/23/2015Q2$2.18$2.27$836.18 million$859.80 millionViewListenView Earnings Details
4/23/2015Q115$2.07$2.10$813.36 million$819.70 millionViewListenView Earnings Details
1/29/2015Q414$2.24$2.29$855.11 million$867.20 millionViewListenView Earnings Details
10/22/2014Q314$2.10$2.15$819.20 million$830.00 millionViewListenView Earnings Details
7/24/2014Q214$2.00$2.06$814.58 million$827.10 millionViewListenView Earnings Details
4/22/2014Q114$1.86$1.91$787.10 million$799.30 millionViewListenView Earnings Details
1/30/2014Q413$1.41$1.42$782.28 million$791.30 millionViewListenView Earnings Details
10/22/2013Q313$1.40$1.50$739.12 million$758.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$1.38$1.42$750.91 million$759.90 millionViewListenView Earnings Details
4/23/2013Q1 2013$1.42$1.44$728.45 million$740.30 millionViewListenView Earnings Details
1/31/2013Q4 2012$1.67$1.70$757.49 million$762.60 millionViewListenView Earnings Details
10/23/2012$1.64$1.64ViewN/AView Earnings Details
7/25/2012$1.64$1.62ViewN/AView Earnings Details
1/31/2012$1.68$1.70ViewN/AView Earnings Details
10/25/2011$1.60$1.62ViewN/AView Earnings Details
7/21/2011$1.57$1.57ViewN/AView Earnings Details
4/21/2011$1.46$1.51ViewN/AView Earnings Details
1/31/2011$1.48$1.54ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for C R Bard (NYSE:BCR)
2017 EPS Consensus Estimate: $11.46
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$2.56$2.64$2.61
Q2 20173$2.80$2.82$2.81
Q3 20173$2.89$3.02$2.96
Q4 20173$2.99$3.15$3.09
Q1 20181$2.88$2.88$2.88
Q2 20181$3.12$3.12$3.12
Q3 20181$3.19$3.19$3.19
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for C R Bard (NYSE:BCR)
Most Recent Dividend:5/12/2017
Annual Dividend:$1.04
Dividend Yield:0.34%
Dividend Growth:6.80% (3 Year Average)
Payout Ratio:14.77% (Trailing 12 Months of Earnings)
8.83% (Based on This Year's Estimates)
8.06% (Based on Next Year's Estimates)
Track Record:45 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for C R Bard (NYSE:BCR)

Dividend History by Quarter for C R Bard (NYSE BCR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/19/2017quarterly$0.260.41%4/27/20175/1/20175/12/2017
12/14/2016quarterly$0.260.47%1/19/20171/23/20172/3/2017
10/12/2016quarterly$0.260.48%10/20/201610/24/201611/4/2016
6/8/2016quarterly$0.260.46%7/14/20167/18/20167/29/2016
4/20/2016quarterly$0.240.46%4/28/20165/2/20165/13/2016
12/9/2015quarterly$0.240.52%1/21/20161/25/20162/5/2016
10/14/2015quarterly$0.240.5%10/22/201510/26/201511/6/2015
6/10/2015quarterly$0.240.56%7/16/20157/20/20157/31/2015
4/15/2015quarterly$0.220.52%4/23/20154/27/20155/8/2015
12/10/2014quarterly$0.220.52%1/22/20151/26/20152/6/2015
10/8/2014quarterly$0.220.59%10/16/201410/20/201410/31/2014
6/11/2014quarterly$0.220.62%7/17/20147/21/20148/1/2014
4/16/2014quarterly$0.210.6%4/24/20144/28/20145/9/2014
12/11/2013quarterly$0.210.63%1/16/20141/21/20141/31/2014
10/9/2013quarterly$0.210.72%10/17/201310/21/201311/1/2013
6/12/2013quarterly$0.210.77%7/18/20137/22/20138/2/2013
4/17/2013quarterly$0.200.8%4/25/20134/29/20135/10/2013
12/12/2012quarterly$0.200.83%1/17/20131/22/20132/1/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for C R Bard (NYSE:BCR)
Insider Ownership Percentage: 0.97%
Institutional Ownership Percentage: 86.89%
Insider Trades by Quarter for C R Bard (NYSE:BCR)
Institutional Ownership by Quarter for C R Bard (NYSE:BCR)
Insider Trades by Quarter for C R Bard (NYSE:BCR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/24/2017Frank Lupisella JrVPSell3,622$304.00$1,101,088.00View SEC Filing  
2/21/2017Jim C BeasleyInsiderSell4,390$245.00$1,075,550.00View SEC Filing  
2/14/2017John A DefordVPSell2,788$240.51$670,541.88View SEC Filing  
2/14/2017John H WeilandVice ChairmanSell14,091$240.49$3,388,744.59View SEC Filing  
2/14/2017John P GroetelaarsInsiderSell732$240.49$176,038.68View SEC Filing  
2/14/2017Timothy M RingChairmanSell14,425$240.50$3,469,212.50View SEC Filing  
2/13/2017John A. DefordVPSell469$240.07$112,592.83View SEC Filing  
2/13/2017John H WeilandVice ChairmanSell1,274$240.00$305,760.00View SEC Filing  
2/13/2017Timothy M RingChairmanSell1,767$240.02$424,115.34View SEC Filing  
2/13/2017Timothy P CollinsInsiderSell642$240.30$154,272.60View SEC Filing  
2/10/2017Betty D LarsonVPSell3,292$240.92$793,108.64View SEC Filing  
2/9/2017Jim C BeasleyInsiderSell8,593$239.58$2,058,710.94View SEC Filing  
2/9/2017John A. DefordVPSell5,816$239.58$1,393,397.28View SEC Filing  
2/9/2017John H WeilandVice ChairmanSell14,281$239.54$3,420,870.74View SEC Filing  
2/9/2017Timothy M RingChairmanSell20,324$239.56$4,868,817.44View SEC Filing  
1/31/2017Gail K NaughtonDirectorSell367$236.22$86,692.74View SEC Filing  
1/11/2017John P GroetelaarsInsiderSell573$235.00$134,655.00View SEC Filing  
1/10/2017Frank Lupisella, Jr.VPSell2,945$232.00$683,240.00View SEC Filing  
1/9/2017Frank Lupisella, Jr.VPSell210$232.00$48,720.00View SEC Filing  
12/30/2016Frank Lupisella JrVPSell237$226.00$53,562.00View SEC Filing  
12/30/2016Jim C BeasleyInsiderSell4,709$225.00$1,059,525.00View SEC Filing  
12/12/2016John A. DefordVPSell15,883$218.03$3,462,970.49View SEC Filing  
12/12/2016John H WeilandVice ChairmanSell11,190$219.67$2,458,107.30View SEC Filing  
12/12/2016Sharon M. LuboffInsiderSell6,000$219.00$1,314,000.00View SEC Filing  
10/28/2016Christopher S. HollandInsiderSell5,724$211.12$1,208,450.88View SEC Filing  
9/28/2016Timothy M RingChairmanSell92,293$227.81$21,025,268.33View SEC Filing  
9/26/2016Timothy M RingChairmanSell110,000$228.96$25,185,600.00View SEC Filing  
9/19/2016Betty D LarsonVPSell4,032$225.33$908,530.56View SEC Filing  
9/6/2016John A. DefordVPSell7,928$221.06$1,752,563.68View SEC Filing  
5/27/2016Christopher S HollandCFOSell3,970$219.89$872,963.30View SEC Filing  
5/17/2016John P GroetelaarsInsiderSell1,162$219.88$255,500.56View SEC Filing  
5/12/2016Tommy G ThompsonDirectorSell500$219.52$109,760.00View SEC Filing  
5/5/2016Tony L WhiteDirectorSell1,200$216.19$259,428.00View SEC Filing  
4/28/2016Jim C BeasleyInsiderSell4,709$215.00$1,012,435.00View SEC Filing  
4/27/2016Sharon M LuboffVPSell10,000$210.00$2,100,000.00View SEC Filing  
3/29/2016Christopher S HollandCFOSell1,650$200.00$330,000.00View SEC Filing  
2/25/2016Jim C BeasleyInsiderSell1,113$195.27$217,335.51View SEC Filing  
2/23/2016Frank Lupisella JrVPSell2,300$190.25$437,575.00View SEC Filing  
2/22/2016Christopher S HollandCFOSell618$190.00$117,420.00View SEC Filing  
2/22/2016Patricia G ChristianVPSell3,182$190.00$604,580.00View SEC Filing  
2/17/2016John A. DefordVPSell661$187.44$123,897.84View SEC Filing  
2/17/2016John H. WeilandCOOSell1,618$187.45$303,294.10View SEC Filing  
2/17/2016Timothy M. RingCEOSell2,453$187.62$460,231.86View SEC Filing  
2/17/2016Timothy P. CollinsinsiderSell974$187.48$182,605.52View SEC Filing  
2/16/2016Anthony WeltersDirectorSell1,784$187.47$334,446.48View SEC Filing  
2/12/2016Christopher S. HollandCFOSell6,297$181.08$1,140,260.76View SEC Filing  
2/12/2016John A. DefordVPSell6,400$182.40$1,167,360.00View SEC Filing  
2/12/2016John H. WeilandCOOSell15,632$182.86$2,858,467.52View SEC Filing  
2/12/2016Timothy M. RingCEOSell24,003$182.76$4,386,788.28View SEC Filing  
2/12/2016Timothy P. CollinsinsiderSell7,893$182.28$1,438,736.04View SEC Filing  
2/10/2016John P. GroetelaarsinsiderSell3,319$187.16$621,184.04View SEC Filing  
2/9/2016John A. DefordVPSell3,407$180.62$615,372.34View SEC Filing  
2/9/2016John H. WeilandCOOSell8,898$181.10$1,611,427.80View SEC Filing  
2/9/2016Timothy M. RingCEOSell4,836$181.20$876,283.20View SEC Filing  
2/9/2016Timothy P. CollinsinsiderSell4,205$181.24$762,114.20View SEC Filing  
2/2/2016Tommy G ThompsonDirectorSell2,319$188.75$437,711.25View SEC Filing  
12/16/2015John H. WeilandCOOSell19,686$188.49$3,710,614.14View SEC Filing  
12/16/2015Patricia G ChristianVPSell1,908$190.00$362,520.00View SEC Filing  
12/14/2015Jim C. BeasleyinsiderSell20,577$184.78$3,802,218.06View SEC Filing  
12/14/2015John A. DefordVPSell5,627$184.00$1,035,368.00View SEC Filing  
12/14/2015John H. WeilandCOOSell33,569$184.25$6,185,088.25View SEC Filing  
11/30/2015Timothy M. RingCEOSell22,052$187.37$4,131,883.24View SEC Filing  
10/29/2015Timothy M. RingCEOSell30,543$184.79$5,644,040.97View SEC Filing  
10/27/2015Gail K. NaughtonDirectorSell2,458$181.99$447,331.42View SEC Filing  
9/29/2015Timothy M. RingCEOSell40,000$185.16$7,406,400.00View SEC Filing  
8/31/2015Timothy M. RingCEOSell40,000$195.17$7,806,800.00View SEC Filing  
8/18/2015Sharon M. LuboffVPSell2,374$199.76$474,230.24View SEC Filing  
8/17/2015Sharon M LuboffVPSell2,030$200.00$406,000.00View SEC Filing  
8/14/2015Tommy G ThompsonDirectorSell1,200$199.25$239,100.00View SEC Filing  
7/13/2015John P GroetelaarsInsiderSell2,456$175.00$429,800.00View SEC Filing  
7/13/2015Timothy M RingCEOSell20,000$176.04$3,520,800.00View SEC Filing  
4/28/2015Tommy G ThompsonDirectorSell1,200$170.43$204,516.00View SEC Filing  
3/23/2015Timothy M RingCEOSell7,628$170.65$1,301,718.20View SEC Filing  
2/23/2015Timothy M RingCEOSell20,000$176.33$3,526,600.00View SEC Filing  
2/19/2015Jim C BeasleyInsiderSell2,884$174.79$504,094.36View SEC Filing  
2/19/2015John H WeilandCOOSell8,413$174.99$1,472,190.87View SEC Filing  
2/19/2015John P GroetelaarsVPSell4,566$175.14$799,689.24View SEC Filing  
2/17/2015Jim C BeasleyInsiderSell9,904$174.58$1,729,040.32View SEC Filing  
2/17/2015John A DefordVPSell6,146$174.58$1,072,968.68View SEC Filing  
2/17/2015John H WeilandCOOSell13,616$174.51$2,376,128.16View SEC Filing  
2/17/2015Timothy M RingCEOSell6,284$174.75$1,098,129.00View SEC Filing  
2/12/2015Patricia G ChristianVPSell1,408$173.97$244,949.76View SEC Filing  
2/12/2015Timothy M RingCEOSell14,363$173.74$2,495,427.62View SEC Filing  
2/12/2015Timothy P CollinsInsiderSell6,564$174.00$1,142,136.00View SEC Filing  
2/9/2015Anthony WeltersDirectorSell1,563$169.02$264,178.26View SEC Filing  
1/22/2015Timothy M RingCEOSell20,000$177.84$3,556,800.00View SEC Filing  
12/22/2014Timothy M RingCEOSell32,325$169.64$5,483,613.00View SEC Filing  
12/17/2014Jim C BeasleyInsiderSell4,525$168.42$762,100.50View SEC Filing  
12/17/2014Sharon M LuboffVPSell3,564$168.36$600,035.04View SEC Filing  
12/16/2014Jim C BeasleyInsiderSell14,634$167.47$2,450,755.98View SEC Filing  
12/16/2014John A DefordVPSell5,626$167.47$942,186.22View SEC Filing  
12/16/2014John H WeilandCOOSell23,093$166.74$3,850,526.82View SEC Filing  
12/16/2014Timothy M RingCEOSell15,232$166.60$2,537,651.20View SEC Filing  
12/15/2014John H WeilandCOOSell13,589$166.56$2,263,383.84View SEC Filing  
12/10/2014Patricia G ChristianVPSell1,269$169.20$214,714.80View SEC Filing  
12/9/2014John H WeilandCOOSell6,350$170.32$1,081,532.00View SEC Filing  
12/9/2014Timothy M RingCEOSell9,550$170.20$1,625,410.00View SEC Filing  
10/27/2014Sharon M LuboffVPSell10,000$158.80$1,588,000.00View SEC Filing  
10/22/2014Timothy M RingCEOSell60,000$149.07$8,944,200.00View SEC Filing  
10/6/2014Timothy M RingCEOSell60,000$148.00$8,880,000.00View SEC Filing  
9/10/2014John H WeilandCOOSell27,179$149.50$4,063,260.50View SEC Filing  
9/2/2014Timothy M RingCEOSell10,228$148.83$1,522,233.24View SEC Filing  
8/4/2014Bronwen K KellyVPSell10,055$150.25$1,510,763.75View SEC Filing  
8/1/2014Timothy M RingCEOSell10,231$149.04$1,524,828.24View SEC Filing  
7/30/2014Timothy P CollinsInsiderSell30,914$150.38$4,648,847.32View SEC Filing  
7/29/2014Sharon M LuboffVPSell5,115$151.37$774,257.55View SEC Filing  
7/1/2014Timothy M RingCEOSell10,231$144.30$1,476,333.30View SEC Filing  
6/2/2014Timothy M RingCEOSell10,231$147.50$1,509,072.50View SEC Filing  
3/3/2014Timothy RingCEOSell10,231$142.23$1,455,155.13View SEC Filing  
2/27/2014Sharon LuboffVPSell9,914$144.86$1,436,142.04View SEC Filing  
2/20/2014Frank Lupisella, Jr.VPSell2,520$140.26$353,455.20View SEC Filing  
2/18/2014Marc BreslawskyDirectorSell2,400$141.34$339,216.00View SEC Filing  
2/11/2014John WeilandCOOSell9,328$135.32$1,262,264.96View SEC Filing  
2/11/2014Sharon LuboffVPSell1,400$135.00$189,000.00View SEC Filing  
1/16/2014John WeilandCOOSell81,500$136.13$11,094,595.00View SEC Filing  
1/13/2014Sharon LuboffVPSell2,500$135.00$337,500.00View SEC Filing  
12/12/2013Jim BeasleyInsiderSell9,802$133.98$1,313,271.96View SEC Filing  
12/12/2013John DefordVPSell2,792$133.98$374,072.16View SEC Filing  
12/10/2013John WeilandCOOSell10,389$137.30$1,426,409.70View SEC Filing  
12/10/2013Timothy RingCEOSell15,623$137.12$2,142,225.76View SEC Filing  
12/2/2013Timothy RingCEOSell10,231$138.85$1,420,574.35View SEC Filing  
11/6/2013David BarrettDirectorSell1,600$138.13$221,008.00View SEC Filing  
10/28/2013Herbert L HenkelDirectorSell2,400$134.66$323,184.00View SEC Filing  
10/28/2013Sharon M AlterioVPSell14,002$134.91$1,889,009.82View SEC Filing  
10/23/2013John H WeilandCOOSell60,210$134.01$8,068,742.10View SEC Filing  
10/21/2013John H WeilandCOOSell84,525$125.62$10,618,030.50View SEC Filing  
10/21/2013Timothy M RingCEOSell8,313$125.52$1,043,447.76View SEC Filing  
10/18/2013Gary D DolchVPSell10,000$125.00$1,250,000.00View SEC Filing  
9/24/2013Timothy RingCEOSell8,313$117.77$979,022.01View SEC Filing  
9/9/2013John A DefordVPSell28,364$117.89$3,343,831.96View SEC Filing  
9/3/2013Timothy RingCEOSell10,231$114.65$1,172,984.15View SEC Filing  
8/30/2013Jim BeasleyInsiderSell1,420$115.33$163,768.60View SEC Filing  
8/21/2013Timothy RingCEOSell8,313$113.24$941,364.12View SEC Filing  
8/12/2013Sharon AlterioVPSell13,379$117.01$1,565,476.79View SEC Filing  
8/5/2013Brian P KellyVPSell28,000$115.69$3,239,320.00View SEC Filing  
8/2/2013David M BarrettDirectorSell1,200$115.70$138,840.00View SEC Filing  
8/2/2013Frank Lupisella JrVPSell10,500$115.61$1,213,905.00View SEC Filing  
8/1/2013John H WeilandCOOSell87,336$115.35$10,074,207.60View SEC Filing  
7/29/2013Timothy P CollinsInsiderSell22,025$113.60$2,502,040.00View SEC Filing  
7/26/2013Anthony WeltersDirectorSell5,600$113.12$633,472.00View SEC Filing  
7/26/2013Jean F HollowayVPSell2,275$113.52$258,258.00View SEC Filing  
7/22/2013Timothy M RingCEOSell8,312$113.58$944,076.96View SEC Filing  
6/21/2013Timothy M RingCEOSell8,312$110.05$914,735.60View SEC Filing  
6/20/2013Gary D DolchVPSell14,569$109.97$1,602,152.93View SEC Filing  
5/21/2013Timothy M RingCEOSell8,312$106.65$886,474.80View SEC Filing  
5/20/2013Marc C BreslawskyDirectorSell2,400$107.20$257,280.00View SEC Filing  
5/8/2013Timothy M RingCEOSell8,312$102.00$847,824.00View SEC Filing  
4/11/2013G Mason MorfitInsiderSell300,000$102.47$30,741,000.00View SEC Filing  
4/9/2013Timothy M RingCEOSell8,312$102.00$847,824.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for C R Bard (NYSE:BCR)
Latest Headlines for C R Bard (NYSE:BCR)
Source:
DateHeadline
finance.yahoo.com logoBecton, Dickinson and Company -- Moody's assigns Baa2 to Becton Dickinson's new euro senior unsecured notes; rating on review for downgrade
finance.yahoo.com - May 23 at 10:59 AM
finance.yahoo.com logoC.R. Bard (BCR) Up 1.6% Since Earnings Report: Can It Continue?
finance.yahoo.com - May 23 at 10:59 AM
finance.yahoo.com logoBecton, Dickinson and Company -- Moody's assigns Ba1 to Becton Dickinson's senior unsecured notes related to Bard
finance.yahoo.com - May 22 at 10:49 AM
americanbankingnews.com logoC R Bard Inc (BCR) Short Interest Update
www.americanbankingnews.com - May 16 at 7:00 AM
zacks.com logoCR Bard (BCR) Hits a 52-Week High: What's Driving the Stock?
www.zacks.com - May 15 at 4:18 PM
finance.yahoo.com logoETFs with exposure to C.R. Bard, Inc. (New Jersey) : May 15, 2017
finance.yahoo.com - May 15 at 4:18 PM
americanbankingnews.com logoZacks Investment Research Downgrades C R Bard Inc (BCR) to Hold
www.americanbankingnews.com - May 12 at 12:26 PM
americanbankingnews.com logoC R Bard Inc (BCR) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - May 11 at 12:32 PM
finance.yahoo.com logoBecton, Dickinson and Company -- Moody's Assigns Ba1 to Becton Dickinson's Exchange Notes
finance.yahoo.com - May 9 at 8:54 PM
americanbankingnews.com logoC R Bard Inc (BCR) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - May 9 at 8:00 AM
americanbankingnews.com logoC R Bard (BCR) Earns Daily News Impact Score of 0.21
www.americanbankingnews.com - May 4 at 1:01 AM
businesswire.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of C. R. Bard, Inc. to Becton, Dickinson and Company for $317 Per Share is Fair ...
www.businesswire.com - May 3 at 12:58 PM
finance.yahoo.com logoETFs with exposure to C.R. Bard, Inc. (New Jersey) : May 2, 2017
finance.yahoo.com - May 2 at 3:54 PM
finance.yahoo.com logoC.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017
finance.yahoo.com - May 1 at 3:51 PM
finance.yahoo.com logoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of C.R. Bard, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
finance.yahoo.com - April 30 at 5:08 PM
americanbankingnews.com logoC R Bard (BCR) Receives News Impact Rating of 0.48
www.americanbankingnews.com - April 30 at 12:27 PM
americanbankingnews.com logo$975.97 Million in Sales Expected for C R Bard Inc (BCR) This Quarter
www.americanbankingnews.com - April 29 at 9:56 AM
finance.yahoo.com logoFive CNBC IQ 100 components are hitting lifetime highs
finance.yahoo.com - April 28 at 4:49 PM
seekingalpha.com logoC. R. Bard, Inc. 2017 Q1 - Results - Earnings Call Slides
seekingalpha.com - April 27 at 9:17 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of C. R. …
finance.yahoo.com - April 27 at 9:17 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of C. R. Bard, Inc. to Becton, Dickinson and Company for $317 Per Share is Fair to Shareholders - BCR
finance.yahoo.com - April 27 at 9:17 PM
americanbankingnews.com logoC R Bard (BCR) Given Media Impact Score of 0.15
www.americanbankingnews.com - April 27 at 4:48 PM
finance.yahoo.com logoHow the BD-Bard Deal Will Create Shareholder Value
finance.yahoo.com - April 27 at 4:17 PM
finance.yahoo.com logoHow BD-Bard Acquisition Will Strengthen International Presence
finance.yahoo.com - April 27 at 4:17 PM
finance.yahoo.com logoC.R. Bard, Inc. (New Jersey) : BCR-US: Dividend Analysis : May 01st, 2017 (record date) : By the numbers : April 27, 2017
finance.yahoo.com - April 27 at 4:17 PM
americanbankingnews.com logo Brokerages Expect C R Bard Inc (BCR) to Announce $2.83 EPS
www.americanbankingnews.com - April 27 at 8:06 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of C.R. Bard, Inc. And Encourages Investors To Contact The Firm For Additional Information
finance.yahoo.com - April 26 at 9:13 PM
finance.yahoo.com logoA Look at BD’s Deal Rationale in Its C.R. Bard Acquisition
finance.yahoo.com - April 26 at 4:11 PM
finance.yahoo.com logoC.R. Bard’s Business Profile and the BD-Bard Deal Rationale
finance.yahoo.com - April 26 at 4:11 PM
finance.yahoo.com logoBD to Acquire C.R. Bard: Deal Highlights and Market Reaction
finance.yahoo.com - April 26 at 11:50 AM
finance.yahoo.com logoMedical Device Maker Bolts Higher On Earnings In Massive Volume
finance.yahoo.com - April 26 at 11:50 AM
americanbankingnews.com logoQ3 2017 EPS Estimates for C R Bard Inc Reduced by Analyst (BCR)
www.americanbankingnews.com - April 26 at 11:28 AM
americanbankingnews.com logoC R Bard Inc (BCR) to Post Q2 2017 Earnings of $2.80 Per Share, KeyCorp Forecasts
www.americanbankingnews.com - April 26 at 10:36 AM
americanbankingnews.com logoC R Bard Inc (BCR) VP Sells $1,101,088.00 in Stock
www.americanbankingnews.com - April 25 at 8:40 PM
finance.yahoo.com logoC.R. BARD INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn ...
finance.yahoo.com - April 25 at 3:47 PM
finance.yahoo.com logoC. R. Bard Stock Trades Ex-Dividend Thursday
finance.yahoo.com - April 25 at 3:47 PM
fool.com logoWhy C.R. Bard Shares Skyrocketed 19.5% Today
www.fool.com - April 24 at 7:25 PM
americanbankingnews.com logoMorgan Stanley Downgrades C R Bard Inc (BCR) to Equal Weight
www.americanbankingnews.com - April 24 at 6:12 PM
americanbankingnews.com logoC R Bard (BCR) Receives Media Sentiment Score of 0.12
www.americanbankingnews.com - April 24 at 6:04 PM
americanbankingnews.com logoJefferies Group LLC Reiterates "Hold" Rating for C R Bard Inc (BCR)
www.americanbankingnews.com - April 24 at 5:22 PM
americanbankingnews.com logoC R Bard Inc (BCR) Receives "Market Perform" Rating from Cowen and Company
www.americanbankingnews.com - April 24 at 4:40 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of C. R. Bard, Inc. to Becton, Dickinson and Company for $317 Per Share is Fair to Shareholders - BCR
finance.yahoo.com - April 24 at 3:50 PM
finance.yahoo.com logoStock Market News for April 24, 2017
finance.yahoo.com - April 24 at 3:50 PM
finance.yahoo.com logoBehind the $24 billion medical device deal
finance.yahoo.com - April 24 at 3:50 PM
finance.yahoo.com logoJim Cramer on Becton Dickinson's Purchase of Bard
finance.yahoo.com - April 24 at 3:50 PM
finance.yahoo.com logoC. R. Bard, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Merger with Becton, Dickinson and Co.
finance.yahoo.com - April 24 at 3:50 PM
finance.yahoo.com logoC.R. BARD, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
finance.yahoo.com - April 24 at 3:50 PM
finance.yahoo.com logo[$$] Don't Succumb to Sticker Shock on Becton Dickinson Deal
finance.yahoo.com - April 24 at 3:50 PM
seekingalpha.com logoMedical tech on the move after C.R. Bard sale
seekingalpha.com - April 24 at 2:20 PM
americanbankingnews.com logoC R Bard Inc (BCR) Releases FY17 Earnings Guidance
www.americanbankingnews.com - April 24 at 11:17 AM

Social

Chart

C R Bard (BCR) Chart for Tuesday, May, 30, 2017

This page was last updated on 5/30/2017 by MarketBeat.com Staff